Cargando…

Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland

BACKGROUND: Research on germline genetic variants relies on enough eligible participants which is difficult to achieve for rare diseases such as childhood cancer. With self-collection kits, participants can contribute genetic samples conveniently from their home. Demographic and clinical factors wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Waespe, Nicolas, Strebel, Sven, Marino, Denis, Mattiello, Veneranda, Muet, Fanny, Nava, Tiago, Schindera, Christina, Belle, Fabien N., Mader, Luzius, Spoerri, Adrian, Kuehni, Claudia E., Ansari, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557596/
https://www.ncbi.nlm.nih.gov/pubmed/34717553
http://dx.doi.org/10.1186/s12874-021-01428-1
_version_ 1784592405379416064
author Waespe, Nicolas
Strebel, Sven
Marino, Denis
Mattiello, Veneranda
Muet, Fanny
Nava, Tiago
Schindera, Christina
Belle, Fabien N.
Mader, Luzius
Spoerri, Adrian
Kuehni, Claudia E.
Ansari, Marc
author_facet Waespe, Nicolas
Strebel, Sven
Marino, Denis
Mattiello, Veneranda
Muet, Fanny
Nava, Tiago
Schindera, Christina
Belle, Fabien N.
Mader, Luzius
Spoerri, Adrian
Kuehni, Claudia E.
Ansari, Marc
author_sort Waespe, Nicolas
collection PubMed
description BACKGROUND: Research on germline genetic variants relies on enough eligible participants which is difficult to achieve for rare diseases such as childhood cancer. With self-collection kits, participants can contribute genetic samples conveniently from their home. Demographic and clinical factors were identified previously that influenced participation in mailed self-collection. People with pre-existing heritable diagnoses might participate differently in germline DNA collection which might render sampling biased in this group. In this nationwide cross-sectional study, we analysed predictive factors of participation in DNA self-collection including heritable diagnoses. METHODS: We identified childhood cancer survivors from the Swiss Childhood Cancer Registry for invitation to germline DNA self-sampling in September 2019. Participants received saliva sampling kits by postal mail at their home, were asked to fill them, sign an informed consent, and send them back by mail. Two reminders were sent to non-participants by mail. We compared demographic, clinical, and treatment information of participants with non-participants using univariable and multivariable logistic regression models. RESULTS: We invited 928 childhood cancer survivors in Switzerland with a median age of 26.5 years (interquartile range 19-37), of which 463 (50%) participated. After the initial send out of the sampling kit, 291 (63%) had participated, while reminder letters led to 172 additional participants (37%). Foreign nationality (odds ratio [OR] 0.5; 95%-confidence interval [CI] 0.4-0.7), survivors aged 30-39 years at study versus other age groups (OR 0.5; CI 0.4-0.8), and survivors with a known cancer predisposition syndrome (OR 0.5; CI 0.3-1.0) were less likely to participate in germline DNA collection. Survivors with a second primary neoplasm (OR 1.9; CI 1.0-3.8) or those living in a French or Italian speaking region (OR 1.3; CI 1.0-1.8) tended to participate more. CONCLUSIONS: We showed that half of childhood cancer survivors participated in germline DNA self-sampling relying completely on mailing of sample kits. Written reminders increased the response by about one third. More targeted recruitment strategies may be advocated for people of foreign nationality, aged 30-39 years, and those with cancer predisposition syndromes. Perceptions of genetic research and potential barriers to participation of survivors need to be better understood. TRIAL REGISTRATION: Biobank: https://directory.bbmri-eric.eu/#/collection/bbmri-eric:ID:CH_HopitauxUniversitairesGeneve:collection:CH_BaHOP Research project: Clinicaltrials.gov: NCT04702321. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-021-01428-1.
format Online
Article
Text
id pubmed-8557596
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85575962021-11-03 Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland Waespe, Nicolas Strebel, Sven Marino, Denis Mattiello, Veneranda Muet, Fanny Nava, Tiago Schindera, Christina Belle, Fabien N. Mader, Luzius Spoerri, Adrian Kuehni, Claudia E. Ansari, Marc BMC Med Res Methodol Research BACKGROUND: Research on germline genetic variants relies on enough eligible participants which is difficult to achieve for rare diseases such as childhood cancer. With self-collection kits, participants can contribute genetic samples conveniently from their home. Demographic and clinical factors were identified previously that influenced participation in mailed self-collection. People with pre-existing heritable diagnoses might participate differently in germline DNA collection which might render sampling biased in this group. In this nationwide cross-sectional study, we analysed predictive factors of participation in DNA self-collection including heritable diagnoses. METHODS: We identified childhood cancer survivors from the Swiss Childhood Cancer Registry for invitation to germline DNA self-sampling in September 2019. Participants received saliva sampling kits by postal mail at their home, were asked to fill them, sign an informed consent, and send them back by mail. Two reminders were sent to non-participants by mail. We compared demographic, clinical, and treatment information of participants with non-participants using univariable and multivariable logistic regression models. RESULTS: We invited 928 childhood cancer survivors in Switzerland with a median age of 26.5 years (interquartile range 19-37), of which 463 (50%) participated. After the initial send out of the sampling kit, 291 (63%) had participated, while reminder letters led to 172 additional participants (37%). Foreign nationality (odds ratio [OR] 0.5; 95%-confidence interval [CI] 0.4-0.7), survivors aged 30-39 years at study versus other age groups (OR 0.5; CI 0.4-0.8), and survivors with a known cancer predisposition syndrome (OR 0.5; CI 0.3-1.0) were less likely to participate in germline DNA collection. Survivors with a second primary neoplasm (OR 1.9; CI 1.0-3.8) or those living in a French or Italian speaking region (OR 1.3; CI 1.0-1.8) tended to participate more. CONCLUSIONS: We showed that half of childhood cancer survivors participated in germline DNA self-sampling relying completely on mailing of sample kits. Written reminders increased the response by about one third. More targeted recruitment strategies may be advocated for people of foreign nationality, aged 30-39 years, and those with cancer predisposition syndromes. Perceptions of genetic research and potential barriers to participation of survivors need to be better understood. TRIAL REGISTRATION: Biobank: https://directory.bbmri-eric.eu/#/collection/bbmri-eric:ID:CH_HopitauxUniversitairesGeneve:collection:CH_BaHOP Research project: Clinicaltrials.gov: NCT04702321. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-021-01428-1. BioMed Central 2021-10-30 /pmc/articles/PMC8557596/ /pubmed/34717553 http://dx.doi.org/10.1186/s12874-021-01428-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Waespe, Nicolas
Strebel, Sven
Marino, Denis
Mattiello, Veneranda
Muet, Fanny
Nava, Tiago
Schindera, Christina
Belle, Fabien N.
Mader, Luzius
Spoerri, Adrian
Kuehni, Claudia E.
Ansari, Marc
Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
title Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
title_full Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
title_fullStr Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
title_full_unstemmed Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
title_short Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
title_sort predictors for participation in dna self-sampling of childhood cancer survivors in switzerland
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557596/
https://www.ncbi.nlm.nih.gov/pubmed/34717553
http://dx.doi.org/10.1186/s12874-021-01428-1
work_keys_str_mv AT waespenicolas predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT strebelsven predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT marinodenis predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT mattielloveneranda predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT muetfanny predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT navatiago predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT schinderachristina predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT bellefabienn predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT maderluzius predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT spoerriadrian predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT kuehniclaudiae predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland
AT ansarimarc predictorsforparticipationindnaselfsamplingofchildhoodcancersurvivorsinswitzerland